Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare access for alopecia areata in the USA is unequal among ethnic groups.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Environmental factors can trigger alopecia areata in identical twins.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

Higher antigliadin antibody levels are linked to alopecia areata severity.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Too much epidermal growth factor can cause hair loss.

Alopecia areata causes patchy hair loss and is often treated with corticosteroids.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Accurate diagnosis of hair loss types is crucial for effective treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

A comprehensive approach is needed to accurately assess alopecia areata severity and guide treatment decisions.

The 308-nm excimer laser helps hair regrowth in some alopecia areata cases but not all.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Alopecia areata is more common in Black and Hispanic people but less diagnosed in those with lower socioeconomic status.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Amoxapine may be effective for treating ejaculatory dysfunction.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.